<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-11-12T14:13:42.133Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-11-12T14:13:42.133Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-11-12T14:13:42.133Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-11-12T14:13:42.133Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-11-12T14:13:42.133Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/NXPL:1794492311000</loc>
    <lastmod>2026-11-12T14:05:11.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NXPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NextPlat Reports Third Quarter 2026 Financial Results</image:title>
      <image:caption>NextPlat Corp reported a third-quarter 2026 loss of $0.28 per share, narrower than the analyst consensus estimate of a $0.46 loss per share. The company released the results on November 12, 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TULP:1794492277000</loc>
    <lastmod>2026-11-12T14:04:37.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TULP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Bloomia Holdings, Inc. Announces September 30, 2026 Financial Results</image:title>
      <image:caption>Bloomia Holdings reported first-quarter fiscal 2026 revenue of $5.0 million, down from $5.2 million a year earlier. Its net loss narrowed to $2.4 million from $2.9 million, while its adjusted EBITDA loss improved to $1.9 million from $2.4 million. The company attributed improved margins and lower cash usage to lower Dutch bulb prices and process improvements focused on quality and waste reduction.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FNT:1794492274000</loc>
    <lastmod>2026-11-12T14:04:34.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FNT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Trading Halt Imposed on FLUENT Corp. by CIRO</image:title>
      <image:caption>CIRO imposed a temporary trading halt on FLUENT Corp. (CSE: FNT.U) on November 11, 2026. The halt is classified as pending news, indicating the company is expected to release information to the market; the article reports no financial results or stock-price impact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BYL:1794492267000</loc>
    <lastmod>2026-11-12T14:04:27.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BYL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Baylin Technologies Reports Q3 2026 Financial Results and Withdraws Fiscal 2026 Outlook</image:title>
      <image:caption>Baylin Technologies reported Q3 2026 revenue of C$35.3 million, up from C$16.8 million a year earlier, and break-even earnings per share versus a loss of C$0.01 per share. The company withdrew its fiscal 2026 outlook, citing shifts in customer capital spending that deferred some orders and increased uncertainty about future demand.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TRT:1794492266000</loc>
    <lastmod>2026-11-12T14:04:26.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Trio-Tech Reports First Quarter Fiscal 2027 Financial Results</image:title>
      <image:caption>Trio-Tech International reported first-quarter fiscal 2027 revenue increased 33% sequentially and 29% year over year. The company attributed the results to its semiconductor testing and equipment business; the article did not provide revenue or profit figures or report stock-price movements.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/LABS:1794492264000</loc>
    <lastmod>2026-11-12T14:04:24.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LABS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>MediPharm Labs Reports Q3 2026 Financial Results</image:title>
      <image:caption>MediPharm Labs reported financial results for the three and nine months ended September 30, 2026. The company recorded its third consecutive quarter of positive Adjusted EBITDA and its second consecutive quarter of positive net income. The article did not provide specific revenue, profit, growth figures, or stock-price movements.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/DAIO:1794492253000</loc>
    <lastmod>2026-11-12T14:04:13.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DAIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Data I/O Corporation Reports Third Quarter 2026 Financial Results</image:title>
      <image:caption>Data I/O Corporation reported third-quarter 2026 revenue of $4.9 million and bookings of $5.0 million, with a net loss of approximately $2.7 million, or $0.27 per share. The company said it is shifting toward software and services, while its acquisition of V-TEK has broadened its offerings into data centers, AI and industrial automation. As of September 30, 2026, Data I/O had $9.4 million in cash and no debt after converting convertible debt into preferred shares earlier in the year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/RMTI:1794492253000</loc>
    <lastmod>2026-11-12T14:04:13.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RMTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Rockwell Medical Announces Third Quarter 2026 Results</image:title>
      <image:caption>Rockwell Medical reported third-quarter 2026 net sales of $19.1 million, up 20% year over year, while gross profit increased 37%, primarily due to higher product volumes. The company said demand and disciplined execution supported its momentum. Its planned combination with Vantive’s global hemodialysis business is projected to generate $400 million to $450 million in annual revenue.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ZEFI:1794492251000</loc>
    <lastmod>2026-11-12T14:04:11.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZEFI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Zefiro Methane Corp. Announces Investor Day and Provides Operational Update</image:title>
      <image:caption>Zefiro Methane Corp. will hold an investor day on November 19, 2026, featuring a company presentation and moderated Q&amp;A. The company reported record fiscal 2026 revenue of USD 42.5 million, up 31.1% year over year, and an approximately USD 40 million backlog of awarded government well-plugging projects expected to run through June 2029. Zefiro also completed a non-brokered private placement that raised approximately CAD 5.0 million in gross proceeds.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OGD:1794492251000</loc>
    <lastmod>2026-11-12T14:04:11.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OGD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Orbit Garant Drilling Reports Record Revenue for Fiscal 2027 First Quarter</image:title>
      <image:caption>Orbit Garant Drilling reported record fiscal 2027 first-quarter revenue of $60.1 million for the quarter ended September 30, 2026, supported by higher drilling activity and improved contract pricing. Rig utilization reached 72%, its highest level since fiscal 2012, amid strong demand in Canada and South America. The company posted a $0.9 million net loss, compared with a $0.3 million profit a year earlier, and said it is continuing its normal course issuer bid to repurchase common shares.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EU:1794492249000</loc>
    <lastmod>2026-11-12T14:04:09.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EU/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>enCore Energy Reports Q3 2026 Financial Results</image:title>
      <image:caption>enCore Energy Corp. reported an 88% year-over-year increase in revenue in the third quarter of 2026. The company attributed the growth to its uranium production operations and said it reflects progress in scaling its in-situ recovery facilities as part of its strategy to supply domestic nuclear fuel. The article did not provide revenue or profit figures or report a stock-price movement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PTHS:1794492247000</loc>
    <lastmod>2026-11-12T14:04:07.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PTHS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Pelthos Therapeutics Announces Third Quarter 2026 Financial Results</image:title>
      <image:caption>Pelthos Therapeutics reported third-quarter 2026 Zelsuvmi net product revenue of $15.2 million, up from $7.1 million a year earlier. Cost of goods sold fell 28% year over year to $1.7 million. The company had $17.7 million in cash as of September 30 and borrowed an additional $10 million from Horizon Technology Finance on October 30. Pelthos reiterated its definitive merger agreement with Castle Creek Biosciences, intended to form a diversified biotechnology company focused on pediatric and dermatological conditions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HYPD:1794492245000</loc>
    <lastmod>2026-11-12T14:04:05.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HYPD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Hyperion DeFi Reports Q3 2026 Financial Results</image:title>
      <image:caption>Hyperion DeFi reported a third consecutive quarter of record net income for Q3 2026 and achieved breakeven-or-better core operating profit and cash flow one quarter ahead of its year-end guidance. The company repaid approximately $8.6 million in principal and interest to retire its Avenue Capital loan and began repurchasing shares under its previously announced $20 million buyback program. Hyperion also wound down its legacy biotech segment, selling the remaining Optejet intellectual property to Arctic Vision in July.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BTCS:1794492242000</loc>
    <lastmod>2026-11-12T14:04:02.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BTCS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BTCS Inc. Reports Record Q3 2026 Financial Results</image:title>
      <image:caption>BTCS Inc. reported record third-quarter 2026 gross profit of $3.5 million and an 86% gross margin, surpassing its $6 million full-year gross profit target with one quarter remaining. The company credited growth in its Imperium business, where paired liquidity pool positions increased from about $8 million to $41 million as it expanded to a multi-chain strategy. BTCS also launched an updated corporate website and new investor materials, and said it plans to keep scaling Imperium as its primary business driver in the fourth quarter.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PODC:1794492240000</loc>
    <lastmod>2026-11-12T14:04:00.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PODC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>PodcastOne Reports Record 1H &amp; Q2 Fiscal 2027 Financial Results</image:title>
      <image:caption>PodcastOne reported record first-half fiscal 2027 revenue of $31.5 million and Adjusted EBITDA of $2.9 million for the six months ended September 30, 2026. The company said the results reflect its ongoing publishing and podcast sales network operations. Management scheduled an investor call and webcast for November 12, 2026, to discuss the results and provide a business update.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CITR:1794492239000</loc>
    <lastmod>2026-11-12T14:03:59.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CITR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CitroTech Inc. Reports Third Quarter 2026 Financial Results</image:title>
      <image:caption>CitroTech reported a third-quarter 2026 loss of $0.10 per share, beating the consensus estimate of a $0.18 loss by 44.4%. Revenue rose 130% year over year to $0.66 million from $288,000, slightly below the $0.67 million estimate as several purchase orders were delayed until the fourth quarter. Management cited cost control as a key factor behind the earnings beat.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AIOS:1794492239000</loc>
    <lastmod>2026-11-12T14:03:59.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AIOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Algo8 AI Inc. Secures C$1.47 Million Follow-On Order from Global Tire Manufacturer</image:title>
      <image:caption>Algo8 AI Inc. announced a follow-on order worth approximately C$1.47 million from a publicly listed global tire manufacturer with 12 plants and annual capacity exceeding 35 million tires. The order expands deployment of Algo8’s industrial AI platform and brings the company’s total contracted value above C$5 million. The article did not report revenue, profit, or a stock-price movement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INKT:1794492238000</loc>
    <lastmod>2026-11-12T14:03:58.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INKT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>MiNK Therapeutics Reports Third Quarter 2026 Financial Results</image:title>
      <image:caption>MiNK Therapeutics reported a third-quarter 2026 net loss of $2.6 million, or $0.50 per share, a 23% reduction in loss per share from the prior-year quarter. The company recorded $0.2 million in pre-commercial revenue from agenT-797 supplied through a named-patient access program and ended the quarter with $7.5 million in cash and cash equivalents. Its Phase 2 agenT-797 study for acute lung injury and respiratory failure is enrolling patients in Ukraine; U.S. dosing is anticipated by year-end 2026, with data expected in the second half of 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KPLT:1794492236000</loc>
    <lastmod>2026-11-12T14:03:56.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KPLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Katapult Holdings, Inc. Reports Third Quarter 2026 Financial Results</image:title>
      <image:caption>Katapult Holdings reported third-quarter 2026 revenue of $753.9 million, up from $443.3 million a year earlier, and adjusted EBITDA of $110.4 million. The company cited $30 million in cost synergies from its recent merger and reported a net loss of $0.38 per diluted share. For the fourth quarter, it forecast revenue of $975 million to $1.03 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TBLD:1794492232000</loc>
    <lastmod>2026-11-12T14:03:52.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TBLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>tinyBuild Raises FY26 Financial Outlook Following Strong Game Launches</image:title>
      <image:caption>tinyBuild raised its FY26 outlook, forecasting revenue of $54 million to $56 million and adjusted EBITDA of $7 million to $8 million for the year ending December 31, 2026. The company cited strong launches: “Probably Stolen” has sold more than 1 million copies, while “ReStory” and “Graveyard Keeper 2” have each surpassed 500,000 copies. tinyBuild said it will continue prioritizing cash generation and disciplined investment in existing franchises and new intellectual property.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NTWK:1794492228000</loc>
    <lastmod>2026-11-12T14:03:48.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NTWK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NetSol Technologies Reports Fiscal First Quarter 2026 Financial Results</image:title>
      <image:caption>NetSol Technologies reported fiscal first-quarter 2026 revenue of $16.4 million, up 9.3% from $15.0 million a year earlier. Subscription and support revenue increased 6.1% to $9.5 million, and services revenue rose 6.3% to $6.4 million. The company posted GAAP net income of $0.16 million, or $0.01 per diluted share, versus a $2.36 million net loss in the prior-year quarter. Gross margin expanded to 50.5% from 39.4%, which the company attributed to revenue mix and capitalization of software development costs.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ANNA:1794492228000</loc>
    <lastmod>2026-11-12T14:03:48.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ANNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AleAnna, Inc. Reports Third Quarter 2026 Financial and Operational Results</image:title>
      <image:caption>AleAnna reported third-quarter 2026 revenue of $20.5 million, more than double the second quarter, and net income of $6.2 million. Adjusted EBITDA nearly tripled to $12.2 million, supported by higher gas production and stronger realized prices; average daily net sales production was approximately 274 kSmc/d. The company appointed upstream energy executive Glen Cayley to its Board of Directors and continued development and permitting work at its Longanesi and Gradizza sites and elsewhere in its Italian portfolio.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GPRO:1794492227000</loc>
    <lastmod>2026-11-12T14:03:47.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GPRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GoPro Delays 10-Q Filing, Reports Material Weaknesses and Revenue Decline</image:title>
      <image:caption>GoPro said it will delay filing its third-quarter 10-Q while it completes accounting and valuation work related to certain financing arrangements. The company has not remediated material weaknesses in its financial reporting controls and is seeking lender waivers for certain debt covenants. Preliminary third-quarter revenue is about $96 million, down from $163 million a year earlier.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NKTX:1794492225000</loc>
    <lastmod>2026-11-12T14:03:45.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NKTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nkarta Announces Positive Integrated Safety Results for NKX019 in Ntrust Clinical Trial</image:title>
      <image:caption>Nkarta reported integrated safety results for NKX019 from 40 patients in its Ntrust clinical trial program, presented at ACR Convergence 2026. The company said there were no cases of CRS, ICANS, IEC-HS or GvHD, and no treatment-related deaths or adverse-event-related discontinuations. CEO Paul J. Hastings said the findings support Nkarta’s view of CAR NK cells as a differentiated approach to autoimmune cell therapy; the article gave no financial results or stock-price impact.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ENGN:1794492221000</loc>
    <lastmod>2026-11-12T14:03:41.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ENGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>enGene Updates Pivotal Bladder Cancer Data and Announces Executive Appointments</image:title>
      <image:caption>enGene Therapeutics reported updated LEGEND Phase 2 results for detalimogene voraplasmid in high-risk, BCG-unresponsive non-muscle invasive bladder cancer, saying Cohort 1 showed improved efficacy. The company said recent FDA discussions established a path to begin a biologics license application submission before the end of 2026, with potential approval in 2027. Dr. Erik T. Goluboff was appointed Chief Medical Officer and Jason Duncan Chief Legal and Administrative Officer, effective November 9, 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OPRX:1794492218000</loc>
    <lastmod>2026-11-12T14:03:38.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OPRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>OptimizeRx Reports Third Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance</image:title>
      <image:caption>OptimizeRx reported third-quarter 2026 revenue of $21.6 million, down 17% from $26.1 million a year earlier, and GAAP net income of $1.2 million, or $0.06 per share. The company lowered its fiscal 2026 revenue guidance to $87 million–$93 million while maintaining adjusted EBITDA guidance of $21 million–$25 million. Since June 30, 2026, it has repaid $9.3 million of debt principal, reducing outstanding principal to $10.4 million. Management cited lower in-year contracted revenue as the reason for the revised outlook and pointed to expected growth in 2027 contracted revenue and the upcoming RFP season.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AXL:1794492217000</loc>
    <lastmod>2026-11-12T14:03:37.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Arrow Exploration Announces Record Production and IC-HZ9 Well Results</image:title>
      <image:caption>Arrow Exploration reported record corporate production of more than 7,000 BOE/D, driven by the IC-HZ9 well on Colombia’s Tapir Block. The well began producing on November 6, 2026, and is currently yielding about 2,400 BOPD gross (1,200 BOPD net) from the Carbonera C7 formation. Arrow had more than US$35 million in cash as of November 1 and spud the IC-HZ10 well on November 8 to target the Ubaque formation. Management plans further horizontal drilling at the Icaco field to support near-term production growth.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AGMR:1794492215000</loc>
    <lastmod>2026-11-12T14:03:35.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AGMR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Silver Mountain Resources Announces First Concentrate Shipment from Reliquias Mine</image:title>
      <image:caption>Silver Mountain Resources completed the sale and first shipment of bulk and zinc concentrates from its 100%-owned Reliquias silver-polymetallic mine in central Peru, with a provisional sales value of approximately US$2.7 million. The shipment marks the start of revenue generation after production restarted in September 2026. The company is ramping up operations and targets processing 800 tonnes per day in the second half of 2027 as it moves toward commercial production.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CURI:1794492213000</loc>
    <lastmod>2026-11-12T14:03:33.000Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CURI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CuriosityStream Reports Third Quarter 2026 Financial Results and Declares Dividend</image:title>
      <image:caption>CuriosityStream reported third-quarter 2026 revenue of $20.7 million, up 13% from $18.4 million a year earlier, and net income of $4.8 million versus a $3.7 million loss. Adjusted EBITDA increased 67%, which management attributed to revenue growth without a proportional rise in fixed costs. The company raised its 2026 outlook to revenue of $79 million–$82 million and adjusted EBITDA of $20 million–$22 million. Its board declared a fourth-quarter cash dividend of $0.085 per share, payable December 15 to shareholders of record December 3, 2026.</image:caption>
    </image:image>
  </url>
</urlset>